Results 91 to 100 of about 28,018 (244)

Recurrent intracranial anaplastic ependymoma with late‐onset giant scalp metastasis

open access: yesClinical Case Reports, 2023
Key Clinical Message Ependymomas are primary brain tumors that predominantly affect individuals between 0 and 4 years of age. Although ependymomas have a propensity for recurrence and the potential to spread within the central nervous system through ...
Gianluca Scalia   +6 more
doaj   +1 more source

European standard clinical practice recommendations for newly diagnosed ependymoma of childhood and adolescence

open access: yes
Ependymomas are tumors of glial origin representing the second most common malignant brain tumors of childhood. Peak incidence in childhood is under 3 years of age.
van Veelen, Marie-Lise   +43 more
core   +1 more source

Uterine Cervix Metastasis of Myxopapillary Ependymoma Originated from the Spinal Cord

open access: yesBalkan Medical Journal, 2016
Background: Myxopapillary ependymomas are well differentiated low-grade tumors which have been documented to local or distant metastasis. In the literature, this is a unique case of myxopapillary ependymoma with metastasis to the uterine cervix. Here, we
Kadir Güzin   +4 more
doaj   +1 more source

Infratentorial C11orf95-fused Gliomas Share Histologic, Immunophenotypic, and Molecular Characteristics of Supratentorial RELA-fused Ependymoma

open access: yesActa Neuropathologica, 2020
Ependymomas are a heterogeneous group of gliomas that occur across CNS compartments and show a wide range of histopathology. DNA methylome profiling and transcriptome analysis have identified at least nine molecular groups of ependymoma separated by ...
Camille Keenan   +15 more
semanticscholar   +1 more source

Clinicopathologic features of infratentorial ependymoma.

open access: yes, 2016
Clinicopathologic features of infratentorial ependymoma.
Iwona Filipek (3155454)   +8 more
core   +1 more source

PRIMARY MYXOPAPILLARY EPENDYMOMA OF FOURTH VENTRICLE: FIRST CASE REPORT IN A TWO-YEAR-OLD CHILD

open access: yesKhyber Medical University Journal, 2020
Myxopapillary ependymoma (MPE), a rare pathological subtype of ependymoma which shows predilection for middle-aged adults between third and fifth decades of life.
Uzma Bukhari   +2 more
doaj   +1 more source

Molecular Grouping and Outcomes of Young Children with Newly Diagnosed Ependymoma Treated on the Multi-Institutional SJYC07 Trial.

open access: yesNeuro-Oncology, 2019
BACKGROUND This report documents the clinical characteristics, molecular grouping and outcome of young children with ependymoma treated prospectively on a clinical trial. METHODS Fifty-four children (aged ≤ 3 years) with newly diagnosed ependymoma were
S. Upadhyaya   +23 more
semanticscholar   +1 more source

Bevacizumab for recurrent ependymoma.

open access: yes, 2009
BACKGROUND: Ependymoma is a rare type of glioma, representing 5% of all CNS malignancies. Radiotherapy (RT) is commonly administered, but there is no standard chemotherapy.
Green, R.M.   +6 more
core   +1 more source

Treatment implications of posterior fossa ependymoma subgroups

open access: yesChinese Journal of Cancer, 2016
Posterior fossa ependymoma comprises two distinct molecular entities, ependymoma_posterior fossa A (EPN_PFA) and ependymoma_posterior fossa B (EPN_PFB), with differentiable gene expression profiles.
Vijay Ramaswamy, Michael D. Taylor
doaj   +1 more source

Survival and functional outcomes of molecularly defined childhood posterior fossa ependymoma: Cure at a cost

open access: yesCancer, 2019
Posterior fossa ependymoma (PFE) comprises 2 groups, PF group A (PFA) and PF group B (PFB), with stark differences in outcome. However, to the authors’ knowledge, the long‐term outcomes of PFA ependymoma have not been described fully.
M. Zápotocký   +17 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy